CDK7 Antibody

Skip to product information
1 of 2

Selleck Chemicals

SKU:F0530-20UL

Regular price €139,00 EUR
Regular price Sale price €139,00 EUR
Sale Sold out
Shipping calculated at checkout.
Size
Quantity
View full details

About the Target

The transcription cycle of RNA polymerase II (Pol II) is regulated by cyclin-dependent kinases (CDKs), with Cdk7 playing a pivotal role. As an effector CDK associated with TFIIH, Cdk7 phosphorylates Pol II and other transcriptional machinery components. Additionally, it acts as a CDK-activating kinase (CAK), activating essential CDKs involved in transcription.

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following CDK7 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CDK7 is commonly interpreted in the context of cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

  • apparent redistribution between cytoplasm and nucleus across matched conditions
  • signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
  • co-patterning with orthogonal markers and control conditions that clarify pathway state
  • time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CDK7. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CDK7 reflect biology rather than handling. When interpreting CDK7, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CDK7 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.

Targets:
CDK7
Research Area:
Cell Signaling
Application:
IHC • IP • WB
Reactivity:
Human • Rat
Specificity:
CDK7 Antibody [K20N22] detects endogenous levels of total CDK7 protein. The antibody does not cross-react with other CDKs.
Host:
Mouse
Clonality:
Monoclonal
Clone:
K20N22
UniProt:
P50613
Storage Buffer:
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.